Santa Fe Community Convention Center Floorplan

Registered Attendees
Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting
(You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
- Full participant list, including joint meeting participants
- Printable Invoices and Invitation Letters
- Scholarship Information
- Lodging Information
Login to My Account page
This meeting took place in 2012
Here are the related meetings in 2021:
MEETING CHANGE TO VIRTUAL: Obesity: From Cell to Patient (J5)
Obesity: From Cell to Patient (EK17)
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Genetic and Molecular Basis of Obesity and Body Weight Regulation (J7)
Organizer(s) Evan D. Rosen, Dawn L. Brasaemle and Bart Staels
January 29—February 3, 2012
Santa Fe Community Convention Center • Santa Fe, NM USA
Abstract Deadline: Sep 29, 2011
Late Abstract Deadline: Nov 1, 2011
Scholarship Deadline: Sep 29, 2011
Early Registration Deadline: Nov 29, 2011
Sponsored by Takeda Pharmaceutical Company Limited
Summary of Meeting:
This conference will cover the latest developments in molecular metabolism relevant to the burgeoning problem of human obesity. Topics of special relevance will include the biology of the adipocyte, novel mechanisms of lipid handling and central control of peripheral metabolism. In addition, new discoveries in epigenetics and fetal programming will be covered. Other topics will be discussed in joint sessions with the Keystone Symposia meeting on Pathogenesis of Diabetes: Emerging Insights into Molecular Mechanisms, including new developments in the genetics of metabolic disease, connections between insulin resistance and inflammation, novel mechanisms of intercellular communication between tissues in metabolism and systems approaches to obesity and diabetes. A scintillating array of world-class speakers has been selected to deliver these insights. Attendees of this meeting will be exposed to the best and the brightest thinkers in this area of critical biomedical importance.
View Scholarships/Awards
This conference will cover the latest developments in molecular metabolism relevant to the burgeoning problem of human obesity. Topics of special relevance will include the biology of the adipocyte, novel mechanisms of lipid handling and central control of peripheral metabolism. In addition, new discoveries in epigenetics and fetal programming will be covered. Other topics will be discussed in joint sessions with the Keystone Symposia meeting on Pathogenesis of Diabetes: Emerging Insights into Molecular Mechanisms, including new developments in the genetics of metabolic disease, connections between insulin resistance and inflammation, novel mechanisms of intercellular communication between tissues in metabolism and systems approaches to obesity and diabetes. A scintillating array of world-class speakers has been selected to deliver these insights. Attendees of this meeting will be exposed to the best and the brightest thinkers in this area of critical biomedical importance.
View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference
SUNDAY, JANUARY 29
MONDAY, JANUARY 30
TUESDAY, JANUARY 31
WEDNESDAY, FEBRUARY 1
THURSDAY, FEBRUARY 2
FRIDAY, FEBRUARY 3
Conference Program Print | View meeting in 12 hr (am/pm) time
SUNDAY, JANUARY 29
19:15—21:30
Welcome and Keynote Session (Joint)
Aldons J. Lusis,
University of California, Los Angeles, USA
Systems Genetics Analysis of Complex Interactions in Cardiometabolic Traits
Systems Genetics Analysis of Complex Interactions in Cardiometabolic Traits
Daniel J. Rader,
University of Pennsylvania, USA
From GWAS to Gene Function: Genetics and Physiology of Lipid and Lipoprotein Metabolism
From GWAS to Gene Function: Genetics and Physiology of Lipid and Lipoprotein Metabolism
08:00—11:15
Inflammation, ER Stress, Insulin Resistance (Joint)
C. Ronald Kahn,
Joslin Diabetes Center and Harvard Medical School, USA
Novel Aspects of Insulin Action and their Role in Development of Insulin Resistance
Novel Aspects of Insulin Action and their Role in Development of Insulin Resistance
Jeffrey M. Friedman,
Rockefeller University, USA
Leptin: From Production to Pathways
Leptin: From Production to Pathways
Gökhan S. Hotamisligil,
Harvard School of Public Health, USA
Inflammation and ER Stress in Obesity and Diabetes
Inflammation and ER Stress in Obesity and Diabetes
Bruce M. Spiegelman,
Harvard Medical School, USA
Irisin, a Novel Myokine that Browns Adipose Tissues and Ameliorates Metabolic Disease
Irisin, a Novel Myokine that Browns Adipose Tissues and Ameliorates Metabolic Disease
Alexander Rauch,
University of Southern Denmark, Denmark
Short Talk: Glucocorticoids Dampen Insulin Sensitivity via the Dimerisation of the Glucocorticoid Receptor in Peripheral Organs
Short Talk: Glucocorticoids Dampen Insulin Sensitivity via the Dimerisation of the Glucocorticoid Receptor in Peripheral Organs
Susan J. Gray,
University of Massachusetts Medical School, USA
Short Talk: KLF15: A Critical Link between Insulin Resistance and ER Stress
Short Talk: KLF15: A Critical Link between Insulin Resistance and ER Stress
14:30—16:30
Workshop 1: Health Disparities (Joint). Supported by Novartis Institutes for BioMedical Research
*
William C. Hsu,
Harvard Medical School, Joslin Diabetes Center, USA
Biology and Clinical Implications of Diabetes in Asian Americans
Biology and Clinical Implications of Diabetes in Asian Americans
Charles N. Rotimi,
NHGRI, National Institutes of Health, USA
Genetics, Environment and Health Disparities in Diabetes among African Americans
Genetics, Environment and Health Disparities in Diabetes among African Americans
Struan F. A. Grant,
Children’s Hospital of Philadelphia Research Institute, USA
Genome Wide Studies of Pediatric Metabolic Traits in Multi-Ethnic Settings
Genome Wide Studies of Pediatric Metabolic Traits in Multi-Ethnic Settings
17:00—19:00
Lipid Droplets and Lipid Handling
*
Deborah M. Muoio,
Duke University Medical Center, USA
Rudolf Zechner,
University of Graz, Austria
Mouse Models of Altered Lipolysis
Mouse Models of Altered Lipolysis
Sheila Collins,
Vanderbilt University Medical Center, USA
Short Talk: Cardiac Natriuretic Peptides Act via p38 MAPK to Induce the Brown Fat Thermogenic Program in Mouse and Human Adipocytes
Short Talk: Cardiac Natriuretic Peptides Act via p38 MAPK to Induce the Brown Fat Thermogenic Program in Mouse and Human Adipocytes
17:00—19:00
Islet Biology
Debbie C. Thurmond,
Indiana University School of Medicine, USA
Molecular Regulators of Insulin Exocytosis
Molecular Regulators of Insulin Exocytosis
Anil Bhushan,
University of California, San Francisco, USA
Epigenetics Control of Islet Formation and Regeneration
Epigenetics Control of Islet Formation and Regeneration
Rohit N. Kulkarni,
Joslin Diabetes Center, Harvard Medical School, USA
Growth Factor Signaling in the Regulation of Islet Function and Proliferation
Growth Factor Signaling in the Regulation of Islet Function and Proliferation
Wook Kim,
Ajou University, South Korea
Short Talk: Cannabinoids Induce Pancreatic Beta-Cell Death by Directly Inhibiting Insulin Receptor Activation
Short Talk: Cannabinoids Induce Pancreatic Beta-Cell Death by Directly Inhibiting Insulin Receptor Activation
08:00—11:15
Genetics (Joint)
*
Aldons J. Lusis,
University of California, Los Angeles, USA
Alan D. Attie,
University of Wisconsin-Madison, USA
Genes for Type 2 Diabetes from Genetics and Genomics
Genes for Type 2 Diabetes from Genetics and Genomics
Joseph H. Nadeau,
Maine Medical Center Research Institute, USA
Epistasis, Fractal Genetics and Systems Properties of Metabolic Traits
Epistasis, Fractal Genetics and Systems Properties of Metabolic Traits
Joel N. Hirschhorn,
Children's Hospital, Boston, USA
Genome-Wide Association Studies and Genetics of Human Obesity
Genome-Wide Association Studies and Genetics of Human Obesity
Nuno Rocha,
Institute of Metabolic Science, University of Cambridge, UK
Short Talk: ARL15: A Novel Player in Metabolic Disease
Short Talk: ARL15: A Novel Player in Metabolic Disease
Carl S. Thummel,
University of Utah School of Medicine, USA
Short Talk: MPC1 Plays an Essential Role in Pyruvate Metabolism in Yeast, Drosophila, and Human Disease
Short Talk: MPC1 Plays an Essential Role in Pyruvate Metabolism in Yeast, Drosophila, and Human Disease
17:00—19:00
Novel Aspects of Adipocyte Biology
Juleen R. Zierath,
Karolinska Institutet, Sweden
Genetic and Environmental Modulators of Insulin Sensitivity
Genetic and Environmental Modulators of Insulin Sensitivity
Barbara Cannon,
Stockholm University, Sweden
Brown and Brite Adipose Tissues: Characteristics and Significance
Brown and Brite Adipose Tissues: Characteristics and Significance
Bart Staels,
Institut Pasteur de Lille, Université Lille, France
Macrophage Polarization in Obesity and Atherosclerosis
Macrophage Polarization in Obesity and Atherosclerosis
J. Andrew Pospisilik,
Van Andel Institute, USA
Short Talk: Rapid Rewiring of Adipocyte Metabolism by a Novel Hedgehog-Ampk Axis
Short Talk: Rapid Rewiring of Adipocyte Metabolism by a Novel Hedgehog-Ampk Axis
17:00—19:00
Novel Regulatory Pathways in Metabolism
*
Steven A. Kliewer,
University of Texas Southwestern Medical Center, USA
Rana K. Gupta,
University of Texas Southwestern Medical Center, USA
Developmental Origin and Molecular Control of Adipose Progenitors
Developmental Origin and Molecular Control of Adipose Progenitors
Matthias Hebrok,
University of California, San Francisco, USA
Hypoxia and Beta-Cell Dysfunction
Hypoxia and Beta-Cell Dysfunction
Ajay Chawla,
Merck Research Labs, USA
Innate Immune Cells Regulate Adipose Tissue Metabolism
Innate Immune Cells Regulate Adipose Tissue Metabolism
Ron F. Morrison,
University of North Carolina, Greensboro, USA
Short Talk: Novel Mechanism of Golgi-Mediated TNFalpha-Induced Inflammatory Gene Expression in Adipocytes
Short Talk: Novel Mechanism of Golgi-Mediated TNFalpha-Induced Inflammatory Gene Expression in Adipocytes
08:00—11:15
Integration of -Omics Data in Diabetes Research (Joint)
Christopher K. Glass,
University of California, San Diego, USA
Genomics and Lipidomics of Macrophage Activation
Genomics and Lipidomics of Macrophage Activation
Elaine Holmes,
Imperial College London, UK
Systems Biology of the Gut Microbiome and Mammalian Metabolism
Systems Biology of the Gut Microbiome and Mammalian Metabolism
Cole Trapnell,
University of Washington, USA
Short Talk: Long Noncoding RNAs Regulate Adipogenesis
Short Talk: Long Noncoding RNAs Regulate Adipogenesis
Ryan Berry,
Yale University, USA
Short Talk: Analysis of Gene Networks in White Adipose Tissue Development Reveals a Role for ETS2 in Adipogenesis
Short Talk: Analysis of Gene Networks in White Adipose Tissue Development Reveals a Role for ETS2 in Adipogenesis
13:00—16:30
Workshop 2: New Therapeutic Targets and Challenges (Joint)
*
David E. Moller,
Eli Lilly and Company, USA
Richard D. DiMarchi,
Indiana University and Novo Nordisk, USA
Keynote Address: Multi-Functional Peptides Targeting Metabolic Disease
Keynote Address: Multi-Functional Peptides Targeting Metabolic Disease
Simeon Taylor,
University of Maryland School of Medicine, USA
SGLT2 Inhibition - Target to Clinical Proof-of-Concept - Lessons Learned
SGLT2 Inhibition - Target to Clinical Proof-of-Concept - Lessons Learned
Dominic P. Behan,
Sentia Medical Sciences, Inc., USA
GPR 119 Agonists for the Treatment of Diabetes
GPR 119 Agonists for the Treatment of Diabetes
Thomas Kjeldsen,
Novo Nordisk, Denmark
Engineering of Next Generation Insulin Analogues
Engineering of Next Generation Insulin Analogues
David E. Kelley,
Merck & Co., Inc., USA
Glucokinase Activators - Target Validation to In-Depth Clinical Testing
Glucokinase Activators - Target Validation to In-Depth Clinical Testing
Paul Emmerson,
Eli Lilly and Company, USA
Short talk: Metabolic Actions through Modulation of FGF Receptor 1c Signaling
Short talk: Metabolic Actions through Modulation of FGF Receptor 1c Signaling
Yang Li,
Amgen Inc., USA
Short Talk: Novel Approaches to Targeting the FGF21 Pathway
Short Talk: Novel Approaches to Targeting the FGF21 Pathway
Rolf F. Kletzien,
Metabolic Solutions Development, Inc., USA
Short Talk: Insulin Sensitization Through a Mitochondrial Metabolic Switch that Modulates Wnt Signaling
Short Talk: Insulin Sensitization Through a Mitochondrial Metabolic Switch that Modulates Wnt Signaling
17:00—19:00
Epigenetics
Mitchell A. Lazar,
Perelman School of Medicine, University of Pennsylvania, USA
Cistromes and the Tissue-Specific Physiology of HDAC3
Cistromes and the Tissue-Specific Physiology of HDAC3
Susanne Mandrup,
University of Southern Denmark, Denmark
Hotspots Orchestrating Adipocyte Differentiation
Hotspots Orchestrating Adipocyte Differentiation
Hironori Waki,
University of Tokyo, Japan
Short Talk: Global Mapping of Cell-Type-Specific Open Chromatin by FAIRE-seq Reveals the Regulatory Role of the NFI Family in Adipocyte Differentiation
Short Talk: Global Mapping of Cell-Type-Specific Open Chromatin by FAIRE-seq Reveals the Regulatory Role of the NFI Family in Adipocyte Differentiation
17:00—19:00
New Concepts in Glucose Metabolism
Matthew G. Vander Heiden,
Massachusetts Institute of Technology, USA
Regulation of Metabolic Pathways to Support Cell Proliferation
Regulation of Metabolic Pathways to Support Cell Proliferation
Donald A. McClain,
University of Utah School of Medicine, USA
O-Glycosylation and Diabetes
O-Glycosylation and Diabetes
Domenico Accili,
Columbia University, USA
Identification of New Drug Targets to Treat Insulin Resistance in the CNS, Liver, and Pancreatic Beta-Cells
Identification of New Drug Targets to Treat Insulin Resistance in the CNS, Liver, and Pancreatic Beta-Cells
Nigel Beaton,
Institute of Food, Nutrition and Health, Switzerland
Short Talk: Tusc5 Controls Insulin Mediated Glucose Uptake by Facilitating Glut4 Membrane Fusion
Short Talk: Tusc5 Controls Insulin Mediated Glucose Uptake by Facilitating Glut4 Membrane Fusion
08:00—11:15
Hormones that Modulate Metabolism and Insulin Sensitivity (Joint)
Eleftheria Maratos-Flier,
Beth Israel Deaconess Medical Center, USA
FGF21: A New Player in Metabolic Homeostasis and Disease
FGF21: A New Player in Metabolic Homeostasis and Disease
Steven A. Kliewer,
University of Texas Southwestern Medical Center, USA
FGF21: From Feast to Famine
FGF21: From Feast to Famine
Philipp E. Scherer,
University of Texas Southwestern Medical Center, USA
Mechanistic Insights into Adipose Tissue and Hepatic Insulin Sensitivity
Mechanistic Insights into Adipose Tissue and Hepatic Insulin Sensitivity
Barbara B. Kahn,
Beth Israel Deaconess Medical Center, Harvard Medical School, USA
Novel Mechanisms by which Adipocytes Regulate Systemic Insulin Sensitivity
Novel Mechanisms by which Adipocytes Regulate Systemic Insulin Sensitivity
Lei Cao,
Ohio State University, USA
Short Talk: White to Brown Fat Phenotypic Switch Induced by Genetic and Environmental Activation of a Hypothalamic-Sympathoneural-Adipocyte Axis
Short Talk: White to Brown Fat Phenotypic Switch Induced by Genetic and Environmental Activation of a Hypothalamic-Sympathoneural-Adipocyte Axis
Stephanie E. Simonds,
Monash University, Australia
Short Talk: Hypertension in Obesity, is Leptin the Culprit?
Short Talk: Hypertension in Obesity, is Leptin the Culprit?
14:30—16:30
Workshop 3: Late Breaking Developments
Ahmed Kablan,
National Institutes of Health, USA
Gs-alpha Deficiency in POMC Neurons Leads to Hyperglycemia with Reduced Serum Insulin Levels and Impaired Counterregulation to Hypoglycemia
Gs-alpha Deficiency in POMC Neurons Leads to Hyperglycemia with Reduced Serum Insulin Levels and Impaired Counterregulation to Hypoglycemia
Craig Hammond,
Eli Lilly and Company, USA
A Novel Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor Increases Plasma GLP-1 Levels and Reduces Body Weight Gain
A Novel Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor Increases Plasma GLP-1 Levels and Reduces Body Weight Gain
Shirly Pinto,
Kallyope, USA
Mechanisms Underlying Diacylglycerol Acyltransferase 1 Inhibition – Potential insight into Modulation of Gut Peptides Release
Mechanisms Underlying Diacylglycerol Acyltransferase 1 Inhibition – Potential insight into Modulation of Gut Peptides Release
Sharon M. Blättler,
Genomics Institute of the Novartis Research Foundation, USA
Yin Yang 1 Deficiency in Skeletal Muscle Protects Against Rapamycin-induced Diabetic-like Symptoms through Activation of Insulin/IGF Signaling
Yin Yang 1 Deficiency in Skeletal Muscle Protects Against Rapamycin-induced Diabetic-like Symptoms through Activation of Insulin/IGF Signaling
Zheng Sun,
Baylor College of Medicine, USA
Dissociation of Fatty Liver and Insulin Resistance in Mice Lacking Hepatic HDAC3
Dissociation of Fatty Liver and Insulin Resistance in Mice Lacking Hepatic HDAC3
Lale Ozcan,
Columbia University, USA
Inhibition of Hepatic Calcium/Calmodulin-Dependent Protein Kinase II Protects against Obesity-Induced Insulin Resistance and Fatty Liver Formation
Inhibition of Hepatic Calcium/Calmodulin-Dependent Protein Kinase II Protects against Obesity-Induced Insulin Resistance and Fatty Liver Formation
Jose M. Irimia-Dominguez,
Indiana University, USA
Inability to Synthesize Glycogen in Liver Leads to Enhanced Lipid Synthesis and Liver Insulin Resistance
Inability to Synthesize Glycogen in Liver Leads to Enhanced Lipid Synthesis and Liver Insulin Resistance
14:30—16:30
Workshop 3: Late Breaking Developments
Marin Gantner,
Lowy Medical Research Institute, USA
Identification of a Novel Energy Expenditure Regulatory Pathway in Brown Adipose Tissue
Identification of a Novel Energy Expenditure Regulatory Pathway in Brown Adipose Tissue
Wen Kong,
Joslin Diabetes Center, USA
STARS Regulates AMPK Phosphorylation and Oxidative Capacity
STARS Regulates AMPK Phosphorylation and Oxidative Capacity
Susana Rodriguez,
Johns Hopkins University School of Medicine, USA
Targeted Chemical-Genetic Metabolic Regulation in vivo
Targeted Chemical-Genetic Metabolic Regulation in vivo
Michael Lutter,
University of Texas Southwestern Medical Center, USA
Melanocortin 4 Receptor Signaling in Habit/Procedural Memory Learning
Melanocortin 4 Receptor Signaling in Habit/Procedural Memory Learning
Kristy L. Townsend,
University of Maine, USA
Deletion of Bone Morphogenetic Protein Receptor 1a (BMPR1a) in POMC Neurons Results in Hyperphagia and Increased Sympathetic Outflow to Brown and White Adipose Tissues
Deletion of Bone Morphogenetic Protein Receptor 1a (BMPR1a) in POMC Neurons Results in Hyperphagia and Increased Sympathetic Outflow to Brown and White Adipose Tissues
Florian W. Kiefer,
Brigham and Women's Hospital, Harvard Medical School, USA
Retinaldehyde Dehydrogenase 1 Determines a Thermogenic Program in White Adipose Tissue
Retinaldehyde Dehydrogenase 1 Determines a Thermogenic Program in White Adipose Tissue
James E. Minchin,
Duke University, USA
Longitudinal in vivo Imaging in Zebrafish Reveals Oscillatory Hyperplastic and Hypertrophic Adipose Tissue Growth is Regulated by a Pre-Patterned Vascular Network
Longitudinal in vivo Imaging in Zebrafish Reveals Oscillatory Hyperplastic and Hypertrophic Adipose Tissue Growth is Regulated by a Pre-Patterned Vascular Network
17:00—19:00
CNS Control of Metabolism
*
Martin G. Myers, Jr.,
University of Michigan, USA
Leptin Signaling in the Brain
Leptin Signaling in the Brain
Allison W. Xu,
University of California, San Francisco, USA
Adaptive Regulation of Energy Balance by Central Melanocortinergic Neurons
Adaptive Regulation of Energy Balance by Central Melanocortinergic Neurons
Jens C. Brüning,
Max Planck Institute for Metabolism Research, Germany
CNS Control of Metabolism
CNS Control of Metabolism
Yong Xu,
Baylor College of Medicine, USA
Short Talk: CNS Circuitry Mediating Estrogenic Effects on Energy Homeostasis
Short Talk: CNS Circuitry Mediating Estrogenic Effects on Energy Homeostasis
17:00—19:00
Insulin Action
*
Barbara B. Kahn,
Beth Israel Deaconess Medical Center, Harvard Medical School, USA
Michael P. Czech,
University of Massachusetts Medical School, USA
New Insights into the Insulin Signaling Pathway
New Insights into the Insulin Signaling Pathway
Morris F. White,
Boston Children's Hospital, Harvard Medical School, USA
The Regulation of Insulin Signaling by Serine/Threonine Phosphorylation of Irs1
The Regulation of Insulin Signaling by Serine/Threonine Phosphorylation of Irs1
Deborah M. Muoio,
Duke University Medical Center, USA
Journal of Lipid Research Lectureship: Mechanisms of Fatty Acid-Induced Insulin Resistance
Journal of Lipid Research Lectureship: Mechanisms of Fatty Acid-Induced Insulin Resistance
Min Lu,
Merck Research Laboroatory, USA
Short Talk: Neuronal SIRT1 Deficiency Causes Central and Whole-Body Insulin Sensitivity
Short Talk: Neuronal SIRT1 Deficiency Causes Central and Whole-Body Insulin Sensitivity
*Session Chair †Invited, not yet responded.
We gratefully acknowledge support for this conference from:
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
![]() |
|
We gratefully acknowledge the generous grant for this conference provided by:
We gratefully acknowledge additional support for this conference from:
![]() |
![]() |
![]() |
![]() |
Takeda California |
|
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: Sarah Lavicka,
Director of Corporate Relations, Email: sarahl@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org, Phone:+1 970-262-1179 |